Evolent Health (EVH) Long-Term Investments (2014 - 2026)

Evolent Health's Long-Term Investments history runs 13 years deep, the most recent figure standing at $9.0 million for Q1 2026.

• In Q1 2026, Long-Term Investments fell 40.53% year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $9.0 million (down 40.53% YoY), while the FY2025 annual figure was $9.0 million, down 40.22% from the prior year.
• Long-Term Investments was $9.0 million for Q1 2026 at Evolent Health, roughly flat from $9.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $16.9 million in Q4 2023 to a low of $2.6 million in Q2 2025.
• Historically, Long-Term Investments has averaged $8.6 million across 5 years, with a median of $8.4 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Long-Term Investments surged 276.85% in 2023, then slumped 68.86% in 2025.
• A 5-year view of Long-Term Investments shows it stood at $4.5 million in 2022, then soared by 276.85% to $16.9 million in 2023, then fell by 11.06% to $15.0 million in 2024, then plunged by 40.22% to $9.0 million in 2025, then retreated by 0.12% to $9.0 million in 2026.
• The last three Long-Term Investments figures came in at $9.0 million (Q1 2026), $9.0 million (Q4 2025), and $8.9 million (Q3 2025), per Business Quant data.